David A. Barton

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

Journal: The British journal of psychiatry : the journal of mental science

Published: July 06, 2026

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTION.

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTION.

Journal: The British journal of psychiatry : the journal of mental science

Published: March 31, 2026

Quality of life and productivity among esketamine responders in a real-world study in Australia and New Zealand.

Quality of life and productivity among esketamine responders in a real-world study in Australia and New Zealand.

Journal: Journal of psychiatric research

Published: January 20, 2026

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial: commentary, author response.

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial: commentary, author response.

Journal: The British journal of psychiatry : the journal of mental science

Published: May 01, 2025

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Journal: The journal of prevention of Alzheimer's disease

Published: January 12, 2025

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study.

Journal: The British journal of psychiatry : the journal of mental science

Published: January 07, 2025

Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study.

Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS study.

Journal: Journal of affective disorders

Published: December 12, 2024

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

Deferiprone in Alzheimer Disease: A Randomized Clinical Trial.

Journal: JAMA neurology

Published: November 04, 2024

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM.

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM.

Journal: The British journal of psychiatry : the journal of mental science

Published: October 14, 2024

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Journal: The British journal of psychiatry : the journal of mental science

Published: December 18, 2023

Pharmacological management of neuropsychiatric symptoms in geriatric traumatic brain injury: a scoping review.

Pharmacological management of neuropsychiatric symptoms in geriatric traumatic brain injury: a scoping review.

Journal: Brain injury

Published: January 11, 2023

Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder.

Measurement of Noradrenaline and Serotonin Metabolites With Internal Jugular Vein Sampling: An Indicator of Brain Monoamine Turnover in Depressive Illness and Panic Disorder.

Journal: Frontiers in psychiatry

Published: November 18, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026